Trajectories of improvement for six depression-related outcomes☆
To access this article, please choose from the options below
☆ Conflict of interest: Drs. Aikens, Klinkman, Kroenke, Nease and Sen have received research support from Eli Lilly, Inc. Dr. Aikens has served as paid consultant to Pfizer. Dr. Klinkman has served as a paid consultant to Wyeth Pharmaceuticals. Dr. Kroenke has received honoraria from Pfizer, Eli Lilly and Wyeth.
PII: S0163-8343(07)00193-4
doi:10.1016/j.genhosppsych.2007.10.003
© 2008 Elsevier Inc. All rights reserved.
